联环药业: 联环药业独立董事年报工作制度（2025年8月修订）

Core Viewpoint - The document outlines the responsibilities and procedures for independent directors in the annual report preparation and disclosure process to ensure the quality and integrity of information disclosed by the company [1][2][3] Group 1: Responsibilities of Independent Directors - Independent directors must diligently fulfill their responsibilities and obligations during the annual report preparation and disclosure process [1] - They are required to study and implement relevant regulations and guidelines issued by the China Securities Regulatory Commission [1] - Independent directors must receive comprehensive reports on the company's operational status and significant matters from management within 30 days after the end of each fiscal year [1] Group 2: Communication and Meetings - The company must arrange at least one meeting between independent directors and the annual audit CPA after the preliminary audit opinion is issued and before the board meeting to discuss any issues found during the audit [2] - Meeting records must be documented and signed by the involved parties [2] Group 3: Reporting and Opinions - Independent directors are required to provide special explanations and independent opinions on external guarantees and related matters in the annual report [2] - They must sign a written confirmation of the annual report, stating their views on its authenticity, accuracy, and completeness [2] Group 4: Support and Confidentiality - The company must provide necessary conditions for independent directors to effectively exercise their powers, ensuring cooperation from relevant personnel [2][3] - Independent directors have a confidentiality obligation and must not disclose the contents of the annual report before its public release [3] Group 5: Independence and Evaluation - Independent directors must conduct an annual self-assessment of their independence and submit the results to the board [3] - The board is responsible for evaluating the independence of serving independent directors annually and issuing a special opinion to be disclosed alongside the annual report [3]